Jump to full article: The Daily Mail and Mail on Sunday (uk), 2009-11-17
Author: Ryan Kisiel and Kate Loveys
Intro: Smokers could soon break their habit with a jab that stops nicotine from being addictive by preventing it from entering the brain, scientists claimed.
As a result the vaccine stops the smoker from deriving any pleasure from inhaling a cigarette. In human trials the vaccine proved successful in 50 per cent of cases.
This would help relieve the NHS of the heavy burden of tobacco-related diseases.
Smoking is believed to cost the NHS between £1.4billion and £1.7billion a year, according to the Centre for Health Economics, University of York.
And yesterday it was announced that the jab has moved one stop closer to hitting the market after pharmaceutical giant Glaxo-SmithKline made a deal with its developer Nabi Pharmaceuticals. . . .
Jean Stephanie, president of GSK’s Biological Divisions, told the Financial Times: ‘If approved, this.... technology could be a novel solution to help the millions of smokers who want to stop smoking and remain abstinent; a habit that is well documented to be very hard to stop permanently.’
Jump to full article » |